Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$49,486,087
+$10,844,710 QoQ
Shares Held
41,258
-1.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#548
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Dodge & Cox holds $7,907,700,561 across 13 Drug Manufacturers - General names. LLY ranks #6 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
23,677,567 | $2,991,423,814 | |
| 2 | GSK |
GSK plc
|
48,197,514 | $2,526,513,683 | |
| 3 | SNY |
Sanofi
|
28,088,274 | $1,198,245,768 | |
| 4 | NVO |
Novo Nordisk A S
|
20,397,110 | $977,837,453 | |
| 5 | NVS |
Novartis AG
|
759,373 | $119,008,936 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
41,258 | $49,486,087 | |
| 7 | MRK |
Merck & Co., Inc.
|
135,750 | $17,443,875 | |
| 8 | AZN |
Astrazeneca PLC
|
55,949 | $10,609,049 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,486,087 | 41,258 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $38,641,377 | 42,012 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $45,665,306 | 42,492 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $33,101,992 | 43,384 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $35,045,330 | 44,957 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $37,236,978 | 45,086 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $34,583,284 | 44,797 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $39,947,034 | 45,090 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $41,627,561 | 45,978 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $36,505,773 | 46,925 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $31,494,584 | 54,029 | Shares | Sole | 2024-02-22 | |
| 2023-09-30 | $29,536,778 | 54,990 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $27,972,312 | 59,645 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $21,141,622 | 61,562 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $23,299,252 | 63,687 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $22,535,554 | 69,694 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $23,079,015 | 71,181 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $20,822,821 | 72,713 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $22,403,651 | 81,108 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $19,571,783 | 84,708 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $19,693,963 | 85,805 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $17,255,816 | 92,366 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $17,983,654 | 106,513 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $18,560,671 | 125,393 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $28,012,719 | 170,622 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $40,437,851 | 291,507 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||